Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 December 2022 | Story Lacea Loader | Photo iFLAIR Photography

During its meeting on 25 November 2022, the Council of the University of the Free State (UFS) unanimously approved the name changes of five residences on the Bloemfontein Campus. 

The UFS Institutional Transformation Plan (ITP) states that a transformed university in South Africa will be one that strives for social justice in everything it does. It will be an institution where its diverse people feel a sense of common purpose and where the symbols and spaces, systems and daily practices all reflect a commitment to openness and engagement. 

“It is in this context that the names and symbols of all 36 residences on the Bloemfontein Campus have been reviewed to ensure that the institutional culture and spaces contribute to an inclusive sense of belonging. The process was started in 2021 through the university’s Naming Committee,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor. 

Subsequently, a process was launched for the review and adjustment of the names of several residences on campus. The recommended name changes express the university’s commitment to courageously grapple with its shared past, present, and future. They are informed by the (2020) Naming and Renaming Policy, which “recognises that the names bestowed on its assets must sustain a harmonious balance between descriptive functions, the university’s origins, the rich history and heritage of the UFS, and the constitutionally democratic society it is designed to serve”. 

As such, the following name changes were approved by the UFS Council:

“The renaming process of the five residences included a variety of activities, all of which focused on building and implementing an engagement and consultation process with the various stakeholders and role player communities,” said Prof Petersen. 

During the renaming process, an important approach of the Naming Committee was to balance the social justice and multilingual agenda of the UFS. Therefore, the languages used in the renaming process reflect not only some of the languages spoken at the UFS (i.e., English, Sesotho, Afrikaans, and isiZulu), but also languages such as isiXhosa, Kiswahili and the use of a name that draws on the national motto in ways that recognise the Khoisan heritage of the Free State and South Africa. 

“The renaming process is an important milestone for the UFS as it symbolises and celebrates the courage and vision of the university community for its commitment to transformation and for participating in a process which aims at producing a names and symbols environment in which all can experience belonging,” said Prof Petersen. 

During the Council meeting, the Naming Committee was thanked for the work done and for the balanced approach to the process of renaming the residences. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept